Best TWAS P=1.83e-08 · Best GWAS P=4.18e-08 conditioned to 0.252
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | CDC16 | 0.23 | 0.26 | lasso | 8 | 0.25 | 2.8e-19 | 5.0 | 5.2 | 2.2e-07 | 0.77 | 0.02 | 0.98 | FALSE |
2 | GTEx | Cells EBV-transformed lymphocytes | CDC16 | 0.14 | 0.09 | lasso | 3 | 0.10 | 2.9e-04 | 5.3 | 5.5 | 4.0e-08 | 0.82 | 0.01 | 0.98 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | CDC16 | 0.17 | 0.13 | lasso | 6 | 0.15 | 4.6e-11 | 5.3 | 5.5 | 3.9e-08 | 0.79 | 0.01 | 0.99 | FALSE |
4 | GTEx | Colon Sigmoid | UPF3A | 0.15 | 0.10 | lasso | 8 | 0.08 | 8.3e-04 | 5.3 | 5.6 | 1.8e-08 | 0.88 | 0.01 | 0.98 | TRUE |
5 | GTEx | Colon Transverse | CDC16 | 0.18 | 0.23 | lasso | 5 | 0.21 | 3.2e-10 | 5.3 | 5.2 | 2.5e-07 | 0.77 | 0.02 | 0.98 | FALSE |
6 | GTEx | Esophagus Gastroesophageal Junction | UPF3A | 0.20 | 0.07 | lasso | 6 | 0.06 | 4.5e-03 | 5.3 | 5.4 | 5.7e-08 | 0.81 | 0.01 | 0.95 | FALSE |
7 | GTEx | Esophagus Mucosa | CDC16 | 0.35 | 0.46 | lasso | 6 | 0.46 | 1.0e-33 | 5.3 | 5.4 | 8.0e-08 | 0.79 | 0.01 | 0.99 | FALSE |
8 | GTEx | Pancreas | CDC16 | 0.09 | 0.14 | lasso | 3 | 0.06 | 1.8e-03 | 5.3 | 5.3 | 1.0e-07 | 0.76 | 0.02 | 0.96 | FALSE |
9 | GTEx | Prostate | CDC16 | 0.17 | 0.16 | lasso | 3 | 0.11 | 1.4e-03 | 5.3 | 5.3 | 1.0e-07 | 0.76 | 0.02 | 0.92 | FALSE |
10 | GTEx | Thyroid | CDC16 | 0.12 | 0.13 | lasso | 2 | 0.11 | 8.2e-09 | 5.3 | 5.3 | 1.1e-07 | 0.77 | 0.01 | 0.99 | FALSE |
11 | GTEx | Whole Blood | CDC16 | 0.31 | 0.20 | lasso | 5 | 0.20 | 4.4e-18 | 5.3 | 5.1 | 2.8e-07 | 0.71 | 0.01 | 0.99 | FALSE |
12 | NTR | Blood | CDC16 | 0.10 | 0.20 | bslmm | 209 | 0.20 | 3.1e-63 | 5.3 | 5.3 | 9.9e-08 | 0.76 | 0.01 | 0.99 | FALSE |
13 | YFS | Blood | CDC16 | 0.28 | 0.54 | enet | 30 | 0.55 | 1.1e-220 | 5.3 | 5.1 | 2.8e-07 | 0.76 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CDC16 | 0.05 | 0.08 | lasso | 4 | 0.08 | 7.2e-09 | 5.3 | 5.2 | 2.2e-07 | 0.72 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CDC16 | 0.05 | 0.04 | blup | 49 | 0.05 | 2.0e-06 | 5.0 | 5.5 | 3.3e-08 | 0.87 | 0.02 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | CDC16 | 0.03 | 0.04 | lasso | 3 | 0.04 | 1.3e-05 | 5.0 | 5.6 | 2.9e-08 | 0.92 | 0.02 | 0.98 | FALSE |
17 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | CDC16 | 0.11 | 0.09 | blup | 49 | 0.09 | 1.8e-04 | 5.0 | 5.3 | 9.7e-08 | 0.76 | 0.02 | 0.96 | FALSE |
18 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | CDC16 | 0.07 | 0.03 | blup | 49 | 0.05 | 6.3e-03 | 5.3 | 5.2 | 2.2e-07 | 0.90 | 0.01 | 0.84 | FALSE |
19 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | UPF3A | 0.10 | 0.09 | lasso | 1 | 0.08 | 3.8e-04 | 5.5 | 5.5 | 4.2e-08 | 1.00 | 0.01 | 0.78 | FALSE |
20 | The Cancer Genome Atlas | Thyroid Carcinoma | CDC16 | 0.06 | 0.09 | lasso | 3 | 0.09 | 3.3e-09 | 5.3 | 5.5 | 2.9e-08 | 0.83 | 0.02 | 0.98 | FALSE |